The United States is experiencing a rise in measles cases due to outbreaks nationwide. Dr. Michael Tjahjadi from Iredell Pediatrics has highlighted the significance of the MMR vaccine in combating these diseases.
Measles, known for its high contagion rate, can lead to severe complications such as brain swelling and pneumonia. “One out of 5 may need hospital care, and between 1 or 3 out of 1,000 will die, even with medical treatment,” Dr. Tjahjadi noted. Mumps can result in facial swelling and other serious health issues, while rubella poses significant risks for pregnant women.
The MMR vaccine contains weakened viruses that prompt the immune system to produce antibodies. This process prepares the body to fight off actual infections effectively. According to Dr. Tjahjadi, “The goals of any vaccine are: Reduce deaths; Reduce hospitalizations; Reduce disease transmission; Reduce symptoms.”
The effectiveness of the MMR vaccine is substantial, with protection rates after two doses being 97% for measles and rubella, and 88% for mumps. The CDC recommends children receive their first dose at 12-15 months old and a second dose at 4-6 years old.
However, certain individuals should consult a doctor before vaccination due to severe allergies or weakened immune systems.
Community protection through herd immunity is crucial since no vaccine offers complete effectiveness. Unvaccinated individuals are more susceptible during outbreaks, which can also endanger those who cannot be vaccinated due to age or health conditions.
In early 2025, Texas reported nearly 300 measles cases resulting in hospitalizations and one death—the first in a decade. Dr. Tjahjadi emphasized that vaccination not only protects individual children but also prevents community outbreaks.
For more information on scheduling an appointment with Dr. Tjahjadi at Iredell Pediatrics, interested parties can call (704) 380-6420.
